Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications

被引：1
|
作者：
Low, En Xian Sarah [1 ]
Wang, Yen-Po [1 ,3 ]
Lu, Ching-Liang [1 ,2 ,3 ]
机构：
[1] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Dept Med, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Brain Sci, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Fac Med, Taipei, Taiwan
来源：
DIGESTIVE DISEASES AND SCIENCES | 2024年 / 69卷 / 01期
关键词：
Cirrhosis; Proton pump inhibitors; Hepatocellular carcinoma; Hepatic decompensation; Spontaneous bacterial peritonitis;
D O I：
10.1007/s10620-023-08153-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The use of proton pump inhibitor (PPI) in cirrhotic patients can be associated with increased risks of long-term mortality, decompensation, hepatic encephalopathy, spontaneous bacterial peritonitis, and infection, but not with short-term mortality. Ensure clear indications at lowest effective dose of is mandatory for the use of PPI among cirrhotic patients.
引用
收藏
页码：7 / 9
页数：3
相关论文
共 50 条
  • [31] Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered Reputation
    Acharya, Chathur
    Bajaj, Jasmohan S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (11):
  • [32] Evaluation of proton pump inhibitors and risks of gastric cancer
    Zeng, Ruijie
    Sha, Weihong
    Wang, Jinghua
    Zhuo, Zewei
    Wu, Huihuan
    Leung, Felix W.
    Chen, Hao
    GUT, 2022, 71 (09) : 1924 - 1926
  • [33] Proton-pump inhibitors: understanding the complications and risks
    Malfertheiner, Peter
    Kandulski, Arne
    Venerito, Marino
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (12) : 697 - 710
  • [34] Proton pump inhibitors: Review of reported risks and controversies
    Brisebois, Simon
    Merati, Albert
    Giliberto, John Paul
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2018, 3 (06): : 457 - 462
  • [35] Proton-pump inhibitors: understanding the complications and risks
    Peter Malfertheiner
    Arne Kandulski
    Marino Venerito
    Nature Reviews Gastroenterology & Hepatology, 2017, 14 : 697 - 710
  • [36] Indications for Inpatient Use of Proton Pump Inhibitors: A Prospective Analysis
    Smith, Zachary
    Sifuentes, Humberto
    Ehrenpreis, Eli
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S41 - S42
  • [37] Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study
    Tsai, Chia-Fen
    Chen, Mu-Hong
    Wang, Yen-Po
    Chu, Chi-Jen
    Huang, Yi-Hsiang
    Lin, Han-Chieh
    Hou, Ming-Chih
    Lee, Fa-Yauh
    Su, Tung-Ping
    Lu, Ching-Liang
    GASTROENTEROLOGY, 2017, 152 (01) : 134 - 141
  • [38] Proton pump inhibitors increase the risk of oral cancer among patients with alcoholic cirrhosis
    Andersen, Astrid Hojmark
    Bossen, Lars
    Jepsen, Peter
    JOURNAL OF HEPATOLOGY, 2020, 73 : S172 - S172
  • [39] Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis
    Garcia-Martinez, Irma
    Frances, Ruben
    Zapater, Pedro
    Gimenez, Paula
    Gomez-Hurtado, Isabel
    Moratalla, Alba
    Lozano-Ruiz, Beatriz
    Bellot, Pablo
    Gonzalez-Navajas, Jose M.
    Such, Jose
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (01) : 147 - 154
  • [40] Subsequent Bacterial Infections in Patients With Cirrhosis and the Role of Proton-Pump Inhibitors Reply
    O'Leary, Jacqueline G.
    Bajaj, Jasmohan S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (11) : 2028 - 2028
12345